Proof of principle trials: exploratory open studies.

Area of Science:

• Clinical pharmacology
• Epileptology
• Pharmaceutical development

Background:

• Early phase IIa studies for antiepileptic drugs (AEDs) often have multiple, competing aims.
• Preclinical data, including mechanism of action and experimental models, are crucial for hypothesizing efficacy in specific seizure types.

Purpose of the Study:

• To define priorities in early phase IIa observational studies for AEDs.
• To guide patient selection for initial AED clinical trials.
• To assess the value of observational studies in drug development.

Main Methods:

• Utilizing preclinical data to inform hypotheses on AED efficacy.
• Selecting patients with refractory epilepsy for initial trials.
• Conducting open, observational studies with predefined questions and criteria.

Main Results:

• Observational studies, while biased, offer advantages over controlled trials: lower cost, greater timeliness, and broader patient inclusion.
• Well-designed observational studies are valuable for assessing clinical benefit and commercial merit.

Conclusions:

• Clear prioritization is essential for early phase IIa AED studies.
• Observational studies provide valuable data for clinicians and pharmaceutical companies in AED development.
• Ethical patient selection is paramount in initial AED clinical trials.